Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice

Brain Research Bulletin

Volumn 40, Issue 3, 1996, Pages 201-207

  Kim, Hack Seang ^a   Park, Woo Kyu ^b   Jang, Choon Gon ^b   Oh, Seikwan ^c  

^a Chungbuk National University   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral sensitization; Cocaine; Dopamine receptor supersensitivity; MK 801; Place conditioning

Indexed keywords

APOMORPHINE; COCAINE; DIZOCILPINE; DIZOCILPINE MALEATE; DOPAMINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ACCELERATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLIMBING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOBILIZATION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; SENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029888897     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/0361-9230(96)00006-8     Document Type: Article

References (56)

1. Bhargava, H. N. Cyclo (Leu-Gly) inhibits the development of morphine analgesic tolerance and dopamine receptor supersensitivity in rat. Life Sci. 27:117-123; 1980.
2. Bouyer, J. J.; Park, D. H.; Joh, T. H.; Pickel, V. M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminal in rat neostriatum. Brain Res. 302:267-275; 1984.
3. Bradberry, C. W. ; Roth, R. H. Cocaine increase extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett. 103:97-102; 1989.
4. Carlsson, M.; Carlsson, A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J. Neural Transm. 75:221-226; 1989.
5. Cheramy, A.; Romo, R.; Godeheu, G.; Baruch, P.; Glowinski, J. In vivo presynaptic control of dopamine release in the cat caudate nucleus - II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19:1081-1090; 1986.
6. Clineschmidt, B. V.; Martin, G. E.; Bunting, P. R.; Rapp, N. L. Central sympathomimetic activity of MK-801, a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev. Res. 2:135-145; 1982.
7. Costentin, J.; Protais, P.; Schwartz, J. C. Rapid and dissociated changes in sensitivities of different dopamine receptors in mouse brain. Nature (London) 257:405-407; 1975.
8. D'Aquila , P. S.; Sias, A.; Gessa, G. L.; Serra, G. The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole. Eur. J. Pharmacol. 224:199-202; 1992.
9. DeWit, H.; Wise, R. A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blocker phentolamine or phenoxybenzamine. Can. J. Psychol. Rev. Can. Psychol. 31:195-203; 1977.
10. Di Chiara, G.; Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85:5274-5278; 1988.
11. Dimpfel, W.; Spuler, M. Dizocilpine, ketamine and phencyclidine: Low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission. Psychopharmacology (Berlin) 101:317-323; 1990.
12. Down, A. W.; Eddy, N. B. The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 46:199-202; 1932.
13. Druhan, J. P.; Jakob, A.; Stewart, J. The development of behavioral sensitization to apomorphine is blocked by MK-801. Eur. J. Pharmacol. 243:73-77; 1993.
14. Ettenberg, A.; Pettit, H. O.; Bloom, F. E.; Koob, G. F. Heroin and cocaine intravenous self-administration in rats: Mediation by separate neural systems. Psychopharmacology (Berlin) 78:204-209; 1982.
15. Friedman, E.; Gershom, S.; Rotrosen, J. Effects of acute cocaine treatment on the turnover of 5-hydroxytryptamine in the rat brain. Br. J. Pharmacol. 54:61-64; 1975.
16. Hadfield, M. G.; Mott, D. E. W.; Ismay, J. A. Cocaine: Effect of in vivo administration on synaptosomal uptake of norepinephrine. Biochem. Pharmacol. 29:1861-1863; 1980.
17. Hadfield, M. G.; Nuggent, E. A. Cocaine: Comparative effect on dopamine uptake in extrapyramidal and limbic systems. Biochem. Pharmacol. 32:744-746; 1983.
18. Hamilton, M. H.; de Belleroche, J. S.; Gardiner, I. M.; Herberg, L. J. Stimulatory effect of n-methyl-d-aspartate on locomotor activity and transmitter release from rat nucleus accumbens. Pharmacol. Biochem. Behav. 25:943-948; 1986.
19. Heikkila, R. E.; Cabbat, F. S.; Mazino, L.; Duvoisin, R. C. Rotational behavior induced by cocaine analogs in rats with unilateral 6-OHDA lesions of the substantia nigra: Dependence upon dopaminergic uptake inhibition. J. Pharmacol. Exp. Ther. 211:189-194; 1979.
20. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:882-890; 1991.
21. Hoffman, D. C. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol. Biochem. Behav. 47:907-912; 1994.
22. Jones, S. M.; Snell, L. D.; Johnson, K. M. Inhibition by phencyclidine of excitatory amino-acid stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology 26:173-179; 1987.
23. Kalivas, P. W.; Duffy, P. The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse 5:48-58; 1990.
24. Kalivas, P. W.; Duffy, P.; DuMars, L. A.; Skinner, C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245:485-491; 1988.
25. Karler, R.; Calder, L. D.; Chaudhry, I. A.; Turkanis, S. A. Blockade of reverse tolerance to cocaine and amphetamine by MK-801. Life Sci. 45:599-606; 1989.
26. Kelley, A. E.; Throne, L. C. NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29:247-254; 1992.
27. Kim, H. S.; Rhee, G. S.; Jung, J. Y.; Lee, J. H.; Jang, C. G.; Park, W. K. Inhibition by noncompetitive NMDA receptor antagonists of apomorphine-induced climbing behavior in mice. Life Sci. 58: 1397-1402; 1996.
28. Koob, G. F.; Bloom, F. E. Cellular and molecular mechanisms of drug dependence. Science 242:715-723; 1988.
29. Krebs, M. O.; Desce, J. M.; Kemel, M. L.; Gauchy, C.; Godeheu, G.; Cheramy, A.; Glowinski, J. Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic NMDA receptors on dopaminergic nerve terminals. J. Neurochem. 56:81-85; 1991.
30. Kuribara, H.; Asami, T.; Ida, I.; Tadokoro, S. Characteristics of the ambulation-increasing effect of the noncompetitive NMDA antagonist MK-801 in mice: Assessment by the coadministration with central-acting drugs. Jpn. J. Pharmacol. 58:11-18; 1992.
31. Layer, R. T.; Kaddis, F. G.; Wallace, L. J. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol. Biochem. Behav. 44:245-247; 1993.
32. Moghaddam, B.; Bunney, B. S. Differential effect of cocaine on extracellular dopamine levels in rat prefrontal cortex and nucleus accumbens: Comparison to amphetamine. Synapse 4:156-161; 1989.
33. Moghaddam, B.; Gruen, R. J.; Roth, R. H.; Bunney, B. S.; Adams, R. N. Effect of L-glutamate on the release of striatal dopamine: In vivo dialysis and electrochemical studies. Brain Res. 518:55-60; 1990.
34. Mucha, R. F.; van der Kooy, D.; O'Shaughnessy, M.; Bucenieks, P. Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243:91-105; 1982.
35. Nestler, E. J. Molecular mechanisms of drug addiction. J. Neurosci. 12:2439-2450; 1992.
36. Petit, H. O.; Pan, H. T.; Parsons, L. H.; Justice, J. B. Extracellular concentration of cocaine and dopamine are enhanced during chronic cocaine administration. J. Neurochem. 55:798-804; 1990.
37. Pitts, D. K.; Marwah, J. Neuropharmacology of cocaine: Role of monoaminergic systems. Monogr. Neural Sci. 13:34-54; 1987.
38. Post, R. M.; Rose, H. Increasing effects of respective cocaine administration in the rat. Nature 260:731-732; 1976.
39. Protais, P.; Costentin, J.; Schwartz, J. C. Climbing behavior induced by apomorphine in mice: A simple test for the study of dopamine receptors in striatum. Psychopharmacology 50:1-6; 1976.
40. Pulvirenti, L.; Sung, R.; Koob, G. F. Microinjection of NMDA but not quisqualate receptor antagonists into the nucleus accumbens modulates intravenous cocaine self-administration in rats. Soc. Neurosci. Abstr. 1098; 1989.
41. Pulvirenti, L.; Swerdlow, N. R.; Koob, G. F. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine. Pharmacol. Biochem. Behav. 40:841-845; 1991.
42. Raffa, R. B.; Ortegon, M. E.; Robisch, D. M.; Martin, G. E. In vivo demonstration of enhancement of MK-801 by glutamate. Life Sci. 44:1593-1599; 1989.
43. Roberts, D. C. S.; Koob, G. F.; Klonoff, P.; Fibiger, H. C. Extinction and recovery of cocaine self-administration following 6-OHDA lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12:781-787; 1980.
44. 3H] dopamine release from the rat striatum in an in vitro model for glutamate action. J. Neurochem. 32:1539-1545; 1979.
45. Roy, S. N.; Bhattacharyya, S.; Pradhan, S.; Pradhan, S. N. Behavioral and neurochemical effects of repeated administration of cocaine in rats. Neuropharmacology 17:559-564; 1978.
46. 1 receptor in the behavioral supersensitivity to dopamine agonist induced by chronic treatment with antidepressants. Brain Res. 527:234-243; 1990.
47. Sesack, S. R.; Pickel, V. M. Ultrastructural basis for modulatory interactions between hippocampal and dopaminergic afferents to the rat nucleus accumbens. Soc. Neurosci. Abstr. 1229; 1989.
48. Smith, A. D.; Bolam, J. P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 13:259-265; 1990.
49. Spyraki, C.; Fibiger, H. C.; Phillips, A. G. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res. 253:185-193; 1982.
50. Spyraki, C.; Fibiger, H. C.; Phillips, A. G. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278-283; 1983.
51. Trujillo, A. K.; Akil, H. Inhibition of morphine tolerance and dependence by NMDA receptor antagonist MK-801. Science 251:85-87; 1991.
52. Wise, R. A.; Bozarth, M. A. A psychomotor theory of addiction. Psychol. Rev. 4:469-492; 1987.
53. Wise, R. A.; Rompre, P. P. Brain dopamine and reward. Annu. Rev. Psychol. 40:191-225; 1989.
54. Wolf, M. E.; Khansa, M. R. Repeated administration of MK-801 produce sensitization to its own locomotor stimulant effect but blocks sensitization to amphetamine. Brain Res. 562:164-168; 1991.
55. 2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 24:531-535; 1986.
56. Yang, C. R.; Mogenson, G. J. Electrophysiological responses of neurons in the nucleus accumbens to hippocampal stimulation and the attenuation of excitatory responses by the mesolimbic dopaminergic system. Brain Res. 324:69-84; 1984.